Annual report pursuant to Section 13 and 15(d)

Restructuring

v3.24.1
Restructuring
12 Months Ended
Dec. 31, 2023
Restructuring and Related Activities [Abstract]  
Restructuring

14. Restructuring

As a result of the Restructuring, the Company incurred $2.5 million in costs for the year ended December 31, 2023. Restructuring costs were comprised of $2.0 million of severance, post-employment benefits, stock-based compensation and outplacement services, and $0.5 million of asset impairment charge and loss on disposal related to the laboratory equipment that was classified as assets held for sale.